| Literature DB >> 375187 |
M Hayat, M Bayssas, G Brulé, P Cappelaere, A Cattan, J Chauvergne, B Clavel, J Gouveia, J Guerrin, E Pommatau, F Muggia, G Mathé.
Abstract
We have conducted a phase II trial of cisdiammino-dichloro platinum (CDDP) which demonstrates its remarkable activity in testis embryonic carcinoma, in ovary carcinoma and in epidermoid cancers, especially head and neck and uterus cervix carcinoma. Its toxicity in mainly digestive and renal. This compound is now indicated in combinations in the case of the above mentioned tumors.Entities:
Mesh：
Substances：
Year: 1979 PMID： 375187
Source DB: PubMed Journal: Nouv Presse Med ISSN： 0301-1518